Related Experiment Video
Updated: Mar 29, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Inflammatory Markers and Procoagulants in Chronic Renal Disease Stages 1-4
Alma Muslimovic1, Senija Rasic1, Denijal Tulumovic2
1Clinic of Nephrology, University Clinical Center Sarajevo, Sarajevo, Bosnia and Herzegovina.
Insights
Chronic kidney disease (CKD) progression is linked to increased inflammation and clotting markers. Monitoring these inflammatory and procoagulant markers may aid in predicting cardiovascular risk in CKD patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Clinical Chemistry
Background:
- Chronic kidney disease (CKD) is a progressive condition characterized by inflammation and a hypercoagulable state.
- This inflammatory and procoagulant state contributes to the high rates of cardiovascular morbidity and mortality observed in CKD patients.
Purpose of the Study:
- To monitor key inflammatory and procoagulant markers across various stages (1-4) of chronic kidney disease.
- To investigate the association between CKD progression and these biochemical markers.
Main Methods:
- Inclusion of 120 adult subjects with CKD stages 1-4 over a 24-month period.
- Laboratory analysis included serum creatinine, albumin, C-reactive protein (CRP), leukocytes, plasma fibrinogen, D-dimer, antithrombin III, coagulation factors VII (FC VII), and coagulation factor VIII (FC VIII).
Main Results:
- Significant increases in CRP, fibrinogen, and FC VIII were observed with CKD progression (stages 1-4).
- Leukocyte counts increased, and antithrombin III levels decreased, though not always statistically significant.
- No significant differences were found in D-dimer and FC VII values across CKD stages.
Conclusions:
- CKD progression is significantly associated with heightened inflammation.
- These inflammatory markers hold potential for prognostic and therapeutic applications in managing CKD.
- The established link between inflammation and cardiovascular risk suggests these biomarkers could predict outcomes and benefit early diagnosis/treatment of cardiovascular disease in CKD patients.
Introduction:
Starting from the point that the chronic kidney disease (CKD) is chronic, inflammatory and hypercoagulable state characterized by an increase in procoagulant and inflammatory markers high cardiovascular morbidity and mortality in these patients could be explained.
Aim:
The aim of the research was to monitor inflammatory markers and procoagulants in various stages of kidney disease (stage 1-4).
Materials And Methods:
The research included 120 subjects older than 18 years with CKD stages 1-4 examined and monitored in Clinic of Nephrology, University Clinical Centre Sarajevo over a period of 24 months. The research included determining the following laboratory parameters: serum creatinine, serum albumin, C-reactive protein, leukocytes in the blood, plasma fibrinogen, D-dimer, antithrombin III, coagulation factors VII (FC VII) and coagulation factor VIII (FC VIII).
Results:
With the progression of kidney disease (CKD stages 1-4), there was a significant increase of inflammatory and procoagulant markers: CRP, fibrinogen and coagulation factor VIII, and an increase in the average values of leukocytes and a reduction in the value of antithrombin III, but without statistical significance. Also, there were no significant differences in the values of D-dimer and coagulation factor VII.
Conclusion:
The progression of kidney disease is significantly associated with inflammation, which could in the future be useful in prognostic and therapeutic purposes. Connection of CKD with inflammation and proven connection of inflammation with cardiovascular risk indicates the potential value of some biomarkers, which could in the future identify as predictors of outcome and could have the benefit in the early diagnosis and treatment of cardiovascular disease in CKD.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology

